The efficacy of CHOEP chemotherapyregimenadministered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneousinvolvement (PTCL)

Autoren: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Datum: 2013

Interessensgebiet: Hämatologie

Das könnte Sie auch interessieren:

Magazin

Preliminary results of a counselling programme for fertilitypreservation in femalecancerpatients: The experience of the GEMME DORMIENTI NETWORK

Autoren: Mariavita Ciccarone , Stefan Hohaus , Alessandro Pulsoni , Paola Cavaceppi , Simona Franzò , Raffaella Fabbri , Laura Cudillo , Roberta Battistini , Alice Di Rocco , Ombretta Annibali , Maria Christina Cox Ida Provenzano, Elisabetta Abruzzese, Daniela Renzi, Cristiano Tesei , Paola Anticoli Borza,

Datum: 2019

Interessensgebiet: Hämatologie

Details lesen

Magazin 10,859

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA STUDY

Autoren: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G

Datum: 2015

Interessensgebiet: stoffwechsel, Diabetes

Details lesen

Magazin 9.54

Epileptic seizures heralding a relapse in high grade gliomas.

Autoren: Di Bonaventura C, Albini M, D'Elia A, Fattouch J,Fanella M, Morano A, Lucignani G, Manfredi M, Colonnese C, Salvati M, Vanacore N, Berardelli A, Giallonardo AT.

Datum: 2017

Interessensgebiet: Epilepsie

Details lesen